Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

$33M Donation will Fund Stem Cell Building at Stanford

Published: Wednesday, March 07, 2007
Last Updated: Wednesday, March 07, 2007
Bookmark and Share
Lorry I. Lokey, the founder of Business Wire will give $33 million to help build new laboratories for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine.

Lorry I. Lokey, the founder of Business Wire and a supporter of education and science, will give a minimum of $33 million to help build a home for Stanford’s Institute for Stem Cell Biology and Regenerative Medicine.

Lokey, who has given away much of his fortune to educational institutions, said he turned his attention to stem cells in 2001, after the Bush administration limited federal funding for stem cell research, discouraging the study of these potentially powerful cells.

“The important thing to me is that stem cells might not only extend life, but also improve the quality of life, as so many people suffer in their later years,” said Lokey, who will turn 80 in March. “But I think stem cells will have applications across the entire life span.”

Lokey’s contribution to the School of Medicine will help launch construction of new stem cell laboratories on campus where scientists will probe the power of these elusive cells in treating conditions as diverse as cancer, stroke and diabetes. Lokey hopes the gift will be more than $33 million; the funds are being held in an account that is expected to grow in value before construction begins.

The anticipated schedule for the building calls for groundbreaking in 2009, with completion in 2011. The building, to be located between Campus Drive and the Center for Clinical Sciences Research, will be the first in a series of structures that will house the Stanford Institutes of Medicine.

“Lorry Lokey is a remarkably brilliant and committed individual. He has become a passionate and highly informed advocate for stem cell research, and is excited by the extraordinary work that is proceeding at Stanford under the banner of our Institute for Stem Cell Biology and Regenerative Medicine,” said Philip Pizzo, MD, dean of the School of Medicine.

“Because of his wonderful gift, we will be able to proceed with planning the space and facilities to house superb faculty and foster the process of basic discovery that ultimately leads to the translation of this knowledge to improve the lives of patients suffering from cancer, neurodegenerative processes, heart failure, immune dysfunction and others,” Pizzo said.

“This is an extraordinarily exciting time in science and medicine, and I am deeply appreciative to Lorry Lokey for his confidence in us and his support for Stanford.”

Lokey said he’s been enjoying giving away his fortune. In recent years, he’s donated about $300 million to various educational institutions, including Stanford, the University of Oregon, Mills College in Oakland, the Technion-Israel Institute of Technology in Israel and his elementary school in Oregon. He oversees his foundation grants under the administration of the Jewish Community Endowment Fund in San Francisco.

“I did not want to go through life without this money being put to work so I could enjoy the fruits of its application. I began to think what it was that made me come out well in business,” he said. “In every question I asked myself, the answer was education.”

Lokey previously has made significant gifts to multiple projects at Stanford, including $20 million to help build the new Lorry I. Lokey Laboratory Building, which opened in 2004 and houses research labs for the departments of Chemistry and Biological Sciences. Lokey said every time he passes the building off Campus Drive, he glows.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Elusive Liver Stem Cell Identified in Mice by Researchers
Researchers have found a previously unknown population of cells in mice that function as liver stem cells. The finding could aid drug testing and increase understanding of liver biology and disease.
Friday, August 07, 2015
Tiny Spheres Of Human Cells Mimic The Brain
Researchers have figured out how to create spheres of neuronal cells resembling the cerebral cortex, making functional human brain tissue available for the first time to study neuropsychiatric diseases such as autism and schizophrenia.
Wednesday, May 27, 2015
Telomere Extension Turns Back Aging Clock In Cultured Cells
Researchers delivered a modified RNA that encodes a telomere-extending protein to cultured human cells. Cell proliferation capacity was dramatically increased, yielding large numbers of cells for study.
Tuesday, January 27, 2015
Stem Cells Faulty In Duchenne Muscular Dystrophy
In a mouse model of Duchenne muscular dystrophy, muscle stem cells express connective-tissue genes associated with fibrosis and muscle weakness, according to a new study.
Thursday, December 18, 2014
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Friday, November 14, 2014
Scientists Discern Signatures of Old Versus Young Stem Cells
A chemical code scrawled on histones determines which genes in that cell are turned on and which are turned off.
Wednesday, July 03, 2013
New Method Allows Human Embryonic Stem Cells to Avoid Immune System Rejection, Study Finds
According to Stanford University researchers, a short-term treatment with three immune-dampening drugs allowed human embryonic stem cells to survive and thrive in mice.
Wednesday, March 09, 2011
Stanford Experts on Method of Deriving Embryonic Stem Cells
In the method single removed cell can divide to produce a line of normal embryonic stem cells.
Thursday, August 24, 2006
Researchers Advance in bid to Turn Mice Stem Cells into Blood Vessels
The goal of the research is to bring together two areas of medical investigation: stem cell research and tissue engineering.
Tuesday, June 27, 2006
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!